US Patent 11181533 Diagnosing and treating Alzheimer's disease
Patent 11181533 was granted and assigned to Dignity Health on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+415 characters)
Article
Patent abstract
Described herein are methods, systems and compositions for the diagnosis, prognosis and treatment of dementia and Alzheimer's disease. Also described are methods, systems and compositions to distinguish between Alzheimer's disease and Parkinson's disease. In various embodiments levels of PACAP and/or SIRT3 are analyzed for the diagnosis, prognosis and treatment of dementia and Alzheimer's disease.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jiong Shi0
Peng Cheng Han0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11181533 Diagnosing and treating Alzheimer's disease
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11181533
Date of patent
November 23, 2021
Patent application number
16984500
Date Filed
August 4, 2020
Patent primary examiner
Find more entities like US Patent 11181533 Diagnosing and treating Alzheimer's disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
